SS Innovations International, Inc. (SSII) Stock

SS Innovations International, Inc. (SSII) is a Healthcare stock trading at $3.65 (as of 2026-08-20), with a market capitalization of $731.48M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

SS Innovations International, Inc. develops surgical robotic systems and related technologies. Its portfolio includes SSI Mantra and SSI Maya, a robotic surgery platform, along with surgical instruments (SSI Mudra) and OMNI 3D HD for live 3D visualization of the surgical field in robotic operating rooms.

Understand SS Innovations International, Inc.: how it makes money

SS Innovations International develops and sells surgical robotic systems and related surgical instruments, including SSI Mantra, SSI Mudra, and an OMNI 3D HD surgical-field viewing solution, with revenue coming from system sales and instruments sales.

Near-term profitability appears to depend on scaling adoption and usage of the SSi Mantra installed base, because instruments and warranty revenue are currently shown as 0.0, while the company is still operating at a negative operating margin.

Revenue by segment (latest quarter)
Systems$0.0B
Instruments$0.0B

Business quality (Weak): The operating model shows early-stage traction signals (systems installed and procedure activity), but the revenue mix and operating losses suggest the business may not yet have meaningful recurring instrument and warranty revenue.

Bull case

  • Installed systems and procedure activity indicate the platform is being adopted and used in surgical workflows: SSi Mantra Systems Installed is 125, and SSi Mantra Completed Procedures is 1859.
  • Telesurgery activity suggests the system is operating in advanced, remote-assisted use cases: Cumulative Telesurgeries Successfully Performed is 150, and SSi Mantra Telesurgeries is 157.

Bear case

  • Recurring revenue may be limited, which can keep profitability under pressure: Instruments Sales Revenue is 0.0, and Warranty Sales Revenue is 0.0, while operating margin is -32.8.
  • System revenue is small relative to the broader operating costs implied by the negative operating margin: System Sales Revenue is 0.01, and operating margin is -32.8.
Valuation — source: SEC EDGAR (first-party)
Price$3.65
Market Cap$731.48M
Price / Book13.70
Price / Sales52.36
FCF Yield-1.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$42.48M
Net Margin-28.5%
Revenue Growth (YoY)39.4%
Financial Health — source: SEC EDGAR
Altman Z-Score11.72 (safe)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderHood River Capital Management LLC ($4.17M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOSudhir Prem Srivastava
Employees378
CountryUS
IPO Date2018-10-17

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Bioventus Inc. (BVS)
  • Beta Bionics, Inc. (BBNX)
  • SpyGlass Pharma, Inc. Common Stock (SGP)
  • SI-BONE, Inc. (SIBN)
  • OrthoPediatrics Corp. (KIDS)
  • AngioDynamics, Inc. (ANGO)
  • MiMedx Group, Inc. (MDXG)
  • Cerus Corporation (CERS)
SSII earnings history · SSII institutional & insider holders · SSII KPIs & operating metrics · SSII financials · SSII investor presentations & press releases · SSII SEC filings · SSII peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.